Targeted molecular therapies are revolutionizing the landscape of cancer treatment by honing in on specific protein interactions that fuel oncogenic processes.These innovative approaches leverage the power of molecular glues—small molecules specifically designed to bind two proteins that ordinarily do not interact, effectively manipulating their behavior within cancer cells.